drugset
drugset / Trial / NCT01541904

Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis

NCT01541904 ↗

Phase 2 Withdrawn Laboratorios Sophia S.A de C.V.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of four doses of PRO-118 ophthalmic solution ophthalmic solution compared with placebo, for the treatment of seasonal (SAC) and perennial (PAC) allergic conjunctivitis.

Timeline

Start
2011-03
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject PRO-118 Unknown 0.015 % —
Subject PRO-118 Unknown 0.02 % —

Indications

conjunctivitis eye allergy